Security key
03753U106
Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (APLS)
CUSIP: 03753U106
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 127,672,507
- Total 13F shares
- 91,648,969
- Share change
- +866,146
- Total reported value
- $4,144,516,571
- Put/Call ratio
- 31%
- Price per share
- $45.22
- Number of holders
- 205
- Value change
- +$31,626,482
- Number of buys
- 126
- Number of sells
- 82
Report period
Q2 2022
Institutions
205
Top holders
10
APLS full security history
Newer quarter: Q3 2022
Previous quarter: Q1 2022
Apellis Pharmaceuticals, Inc. SEC filings
Apellis Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03753U106
Recent filing periods:
Top shareholders of APLS - Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
11%
|
14,199,294
|
$721,466,000 | — | 31 Mar 2022 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
7.4%
|
9,450,000
|
$480,155,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.7%
|
8,569,170
|
$435,400,000 | — | 31 Mar 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
6.2%
|
7,884,839
|
$400,629,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.6%
|
5,923,920
|
$300,993,000 | — | 31 Mar 2022 | |
| EcoR1 Capital, LLC |
13F
|
Company |
4.1%
|
5,183,431
|
$263,370,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
2.3%
|
2,906,456
|
$147,677,000 | — | 31 Mar 2022 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
2.1%
|
2,704,390
|
$137,410,000 | — | 31 Mar 2022 | |
| Octagon Capital Advisors LP |
13F
|
Company |
1.8%
|
2,340,059
|
$118,898,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
1,493,520
|
$75,885,000 | — | 31 Mar 2022 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.2%
|
1,481,700
|
$75,285,000 | — | 31 Mar 2022 | |
| FMR LLC |
13F
|
Company |
1.1%
|
1,397,592
|
$71,012,000 | — | 31 Mar 2022 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1%
|
1,324,964
|
$67,235,000 | — | 31 Mar 2022 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1%
|
1,321,558
|
$67,149,000 | — | 31 Mar 2022 | |
| Boxer Capital, LLC |
13F
|
Company |
1%
|
1,303,700
|
$66,241,000 | — | 31 Mar 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.99%
|
1,266,238
|
$64,337,000 | — | 31 Mar 2022 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.88%
|
1,125,000
|
$57,161,000 | — | 31 Mar 2022 | |
| Bellevue Group AG |
13F
|
Company |
0.86%
|
1,098,712
|
$55,825,000 | — | 31 Mar 2022 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.72%
|
915,163
|
$46,499,000 | — | 31 Mar 2022 | |
| Logos Global Management LP |
13F
|
Company |
0.7%
|
900,000
|
$45,729,000 | — | 31 Mar 2022 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
0.7%
|
897,956
|
$45,625,000 | — | 31 Mar 2022 | |
| NORGES BANK |
13F
|
Company |
0.64%
|
814,965
|
$41,408,372 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.6%
|
765,202
|
$38,880,000 | — | 31 Mar 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.51%
|
655,308
|
$33,297,000 | — | 31 Mar 2022 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.49%
|
628,645
|
$31,941,000 | — | 31 Mar 2022 | |
| FIDUCIARY TRUST CO |
13F
|
Company |
0.44%
|
564,826
|
$28,699,000 | — | 31 Mar 2022 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.43%
|
554,000
|
$28,149,000 | — | 31 Mar 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.43%
|
544,311
|
$27,657,000 | — | 31 Mar 2022 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.4%
|
513,027
|
$26,067,000 | — | 31 Mar 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.39%
|
500,254
|
$25,418,000 | — | 31 Mar 2022 | |
| S.c.a. Candriam |
13F
|
Individual |
0.37%
|
466,095
|
$23,681,000 | — | 31 Mar 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.34%
|
429,252
|
$21,810,000 | — | 31 Mar 2022 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.31%
|
390,140
|
$19,823,015 | — | 31 Mar 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.3%
|
381,950
|
$19,406,000 | — | 31 Mar 2022 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.3%
|
377,000
|
$19,155,000 | — | 31 Mar 2022 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.26%
|
332,202
|
$16,879,000 | — | 31 Mar 2022 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.25%
|
325,000
|
$16,513,000 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.25%
|
315,480
|
$16,029,000 | — | 31 Mar 2022 | |
| NATIXIS |
13F
|
Company |
0.21%
|
268,100
|
$13,622,000 | — | 31 Mar 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.21%
|
263,645
|
$13,733,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.2%
|
253,389
|
$12,875,000 | — | 31 Mar 2022 | |
| CAAS CAPITAL MANAGEMENT LP |
13F
|
Company |
0.2%
|
250,000
|
$12,703,000 | — | 31 Mar 2022 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.2%
|
250,000
|
$12,703,000 | — | 31 Mar 2022 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.19%
|
247,686
|
$12,585,000 | — | 31 Mar 2022 | |
| Maven Securities LTD |
13F
|
Company |
0.17%
|
221,400
|
$11,249,000 | — | 31 Mar 2022 | |
| Lombard Odier Asset Management (Switzerland) SA |
13F
|
Company |
0.17%
|
221,251
|
$11,242,000 | — | 31 Mar 2022 | |
| Avidity Partners Management LP |
13F
|
Company |
0.16%
|
210,000
|
$10,670,000 | — | 31 Mar 2022 | |
| Artal Group S.A. |
13F
|
Company |
0.16%
|
200,000
|
$10,162,000 | — | 31 Mar 2022 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.15%
|
195,820
|
$9,950,000 | — | 31 Mar 2022 | |
| BANQUE PICTET & CIE SA |
13F
|
Company |
0.15%
|
189,223
|
$9,614,000 | — | 31 Mar 2022 |
Institutional Holders of Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (APLS) as of Q2 2022
As of 30 Jun 2022,
Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (APLS) was held by
205 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
91,648,969 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, Avoro Capital Advisors LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., EcoR1 Capital, LLC, STATE STREET CORP, Octagon Capital Advisors LP, JENNISON ASSOCIATES LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
206
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
206
Q2 2022 holders
205
Holder diff
-1
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.